Literature DB >> 8023818

The pathology of vasculitis involving the kidney.

J C Jennette1, R J Falk.   

Abstract

The kidneys are frequently affected by systemic vasculitides. This is not surprising given the numerous vessels within the renal parenchyma. The kidneys are most often involved by small vessel vasculitides, such as microscopic polyangiitis (microscopic polyarteritis), Wegener's granulomatosis, Henoch-Schönlein purpura, and cryoglobulinemic vasculitis. These vasculitides cause renal dysfunction predominantly by inducing glomerular inflammation with resultant nephritis and renal failure. Microscopic polyangiitis (microscopic polyarteritis) and Wegener's granulomatosis are associated with and may be caused by antineutrophil cytoplasmic autoantibodies. Henoch-Schönlein purpura is caused by immunoglobulin (Ig) A-dominant immune complex localization in small vessels. Cryoglobulinemic vasculitis is sometimes induced by hepatitis C infection. Necrotizing medium-sized vessel vasculitides, such as classic polyarteritis nodosa and Kawasaki's disease, are less frequent causes of renal disease. They cause infarction secondary to thrombosis of inflamed major extrarenal and intrarenal arteries, and may lead to life-threatening hemorrhage from rupture of aneurysms. Large vessel vasculitides, such as giant cell (temporal) arteritis and Takayasu arteritis, only rarely injure the kidneys, usually by ischemia secondary to vasculitic involvement of the renal arteries or abdominal aorta. This ischemia can cause renovascular hypertension.

Entities:  

Mesh:

Year:  1994        PMID: 8023818     DOI: 10.1016/s0272-6386(12)80171-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  16 in total

Review 1.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Giant cell arteritis presenting as renal vasculitis.

Authors:  Y K Govil; K Sabanathan; D Scott
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

Review 3.  Endothelium-neutrophil interactions in ANCA-associated diseases.

Authors:  Lise Halbwachs; Philippe Lesavre
Journal:  J Am Soc Nephrol       Date:  2012-09       Impact factor: 10.121

4.  Classic polyarteritis nodosa presenting rare clinical manifestations in a patient with hemophilia A.

Authors:  Tadashi Matsushita; Hiroaki Adachi; Hidetaka Watanabe; Yoshie Shimoyama; Tatsuya Adachi; Gen Sobue; Masafumi Ito; Tetsuhito Kojima; Hidehiko Saito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 5.  Pulmonary vasculitis: diagnosis and endovascular therapy.

Authors:  Kiran Batra; Murthy Chamarthy; Rodrigo Caruso Chate; Kirk Jordan; Fernando Uliana Kay
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 6.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

Review 7.  Renal paradoxical embolism in a hypertensive young adult without acute ischemic symptoms.

Authors:  Mizuho Nara; Atsushi Komatsuda; Masumi Fujishima; Naohito Fujishima; Miho Nara; Takako Iino; Hiroshi Ito; Ken-ichi Sawada; Hideki Wakui
Journal:  Clin Exp Nephrol       Date:  2011-03-24       Impact factor: 2.801

8.  ANCA-negative pauci-immune crescentic glomerulonephritis complicated with recurrent massive gastrointestinal hemorrhage.

Authors:  Tamaki Harada; Takashi Uzu; Tomoko Namba; Ryohei Yamamoto; Ken Takahara; Atsushi Yamauchi
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

9.  Renal infarction caused by medium vessel vasculitis.

Authors:  Vinothkumar Kavarthapol Jayaraman; Aron Chakera
Journal:  BMJ Case Rep       Date:  2015-04-24

Review 10.  Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist.

Authors:  Spyros A Papiris; Effrosyni D Manali; Ioannis Kalomenidis; Giorgios E Kapotsis; Anna Karakatsani; Charis Roussos
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.